Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro Balsa

Showing results (231-240 of 246) with videos related to

Pageof 25
Sort By:
Plos One|May 8, 2018
Validation study of genetic biomarkers of response to TNF inhibitors in rheumatoid arthritisRosario Lopez-Rodriguez, Eva Perez-Pampin, Ana Marquez, et al.
Plos One|March 1, 2019
Evaluation of 12 GWAS-drawn SNPs as biomarkers of rheumatoid arthritis response to TNF inhibitors. A potential SNP association with response to etanerceptAida Ferreiro-Iglesias, Ariana Montes, Eva Perez-Pampin, et al.
Annals of the Rheumatic Diseases|September 20, 2011
Replication of association of the interleukin 23 receptor rs1343151 variant with rheumatoid arthritis in Caucasian sample setsMichael Chen-Xu, Ruth Topless, Cushla McKinney, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 31, 2020
HLA-B*08 Identified as the Most Prominently Associated Major Histocompatibility Complex Locus for Anti-Carbamylated Protein Antibody-Positive/Anti-Cyclic Citrullinated Peptide-Negative Rheumatoid ArthritisCristina Regueiro, Desire Casares-Marfil, Karin Lundberg, et al.
Scientific Reports|January 7, 2017
Influence of coronary artery disease and subclinical atherosclerosis related polymorphisms on the risk of atherosclerosis in rheumatoid arthritisRaquel López-Mejías, Alfonso Corrales, Esther Vicente, et al.
Arthritis Research & Therapy|March 12, 2014
Lack of validation of genetic variants associated with anti-tumor necrosis factor therapy response in rheumatoid arthritis: a genome-wide association study replication and meta-analysisAna Márquez, Aida Ferreiro-Iglesias, Cristina L Dávila-Fajardo, et al.
Reumatologia Clinica|July 17, 2017
Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring in clinical practice: the spanish cohort of the COMORA studyAlejandro Balsa, Leticia Lojo-Oliveira, Mercedes Alperi-López, et al.
Annals of the Rheumatic Diseases|January 23, 2014
Identification of secreted phosphoprotein 1 gene as a new rheumatoid arthritis susceptibility geneSteven Gazal, Karim Sacre, Yannick Allanore, et al.
Scientific Reports|August 19, 2016
Influence of elevated-CRP level-related polymorphisms in non-rheumatic Caucasians on the risk of subclinical atherosclerosis and cardiovascular disease in rheumatoid arthritisRaquel López-Mejías, Fernanda Genre, Sara Remuzgo-Martínez, et al.
Arthritis Research & Therapy|April 18, 2015
Rheumatoid arthritis response to treatment across IgG1 allotype - anti-TNF incompatibility: a case-only studyAriana Montes, Eva Perez-Pampin, Federico Navarro-Sarabia, et al.
Pageof 25

Showing results (231-240 of 246) with videos related to

Sort By:
Pageof 25
Plos One|May 8, 2018
Validation study of genetic biomarkers of response to TNF inhibitors in rheumatoid arthritisRosario Lopez-Rodriguez, Eva Perez-Pampin, Ana Marquez, et al.
Plos One|March 1, 2019
Evaluation of 12 GWAS-drawn SNPs as biomarkers of rheumatoid arthritis response to TNF inhibitors. A potential SNP association with response to etanerceptAida Ferreiro-Iglesias, Ariana Montes, Eva Perez-Pampin, et al.
Annals of the Rheumatic Diseases|September 20, 2011
Replication of association of the interleukin 23 receptor rs1343151 variant with rheumatoid arthritis in Caucasian sample setsMichael Chen-Xu, Ruth Topless, Cushla McKinney, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 31, 2020
HLA-B*08 Identified as the Most Prominently Associated Major Histocompatibility Complex Locus for Anti-Carbamylated Protein Antibody-Positive/Anti-Cyclic Citrullinated Peptide-Negative Rheumatoid ArthritisCristina Regueiro, Desire Casares-Marfil, Karin Lundberg, et al.
Scientific Reports|January 7, 2017
Influence of coronary artery disease and subclinical atherosclerosis related polymorphisms on the risk of atherosclerosis in rheumatoid arthritisRaquel López-Mejías, Alfonso Corrales, Esther Vicente, et al.
Arthritis Research & Therapy|March 12, 2014
Lack of validation of genetic variants associated with anti-tumor necrosis factor therapy response in rheumatoid arthritis: a genome-wide association study replication and meta-analysisAna Márquez, Aida Ferreiro-Iglesias, Cristina L Dávila-Fajardo, et al.
Reumatologia Clinica|July 17, 2017
Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring in clinical practice: the spanish cohort of the COMORA studyAlejandro Balsa, Leticia Lojo-Oliveira, Mercedes Alperi-López, et al.
Annals of the Rheumatic Diseases|January 23, 2014
Identification of secreted phosphoprotein 1 gene as a new rheumatoid arthritis susceptibility geneSteven Gazal, Karim Sacre, Yannick Allanore, et al.
Scientific Reports|August 19, 2016
Influence of elevated-CRP level-related polymorphisms in non-rheumatic Caucasians on the risk of subclinical atherosclerosis and cardiovascular disease in rheumatoid arthritisRaquel López-Mejías, Fernanda Genre, Sara Remuzgo-Martínez, et al.
Arthritis Research & Therapy|April 18, 2015
Rheumatoid arthritis response to treatment across IgG1 allotype - anti-TNF incompatibility: a case-only studyAriana Montes, Eva Perez-Pampin, Federico Navarro-Sarabia, et al.
Pageof 25